Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...
U.S. expects Iranian responses in next 48 hours, Axios says MOU would declare end to the war, start of 30-day period of negotiations U.S. stock index futures extend gains following Axios report May 6 ...
According to Stanford’s 2026 AI Index, AI is sprinting, and we’re struggling to keep up. If you’re following AI news, you’re probably getting whiplash. AI is a gold rush. AI is a bubble. AI is taking ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Kara Greenberg is a senior news editor for Investopedia, where she does work writing, editing, and assigning daily markets and investing news. Prior to joining Investopedia, Kara was a researcher and ...
Hi, everyone. Let's get started. Welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Priyanka Grover, and I'm part of the JPMorgan Biotech team. Today, our next presenting company is ...
While artificial intelligence (AI) may solve certain sustainability issues in the future, the technology’s environmental footprint is already a topic of much discussion today. To help society bridge ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...
Despite having a market capitalization of about 10 percent of Bitcoin, stablecoins are growing in influence because of the interconnections with mainstream financial markets that stem both from their ...
One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...